Mefenamic acid, (MFA), a carboxylic acid-containing nonsteroidal anti-inflammatory drug (NSAID) is metabolized into the chemically-reactive, MFA-1-O-acyl-glucuronide (MFA-1-O-G), MFA-acyl-adenylate (MFA-AMP), and the MFA-S-acyl-CoA (MFA-CoA), all of which are electrophilic and capable of acylating nucleophilic sites on biomolecules. In this study, we investigate the non-enzymatic ability of each MFA acyl-linked metabolite to transacylate amino and thiol functional groups on the acceptor biomolecules glycine (Gly), taurine (Tau), and NAC, and MFA-GSH reacts nonenzymatically with the thiol functional group of GSH, all of which may potentially elicit an idiosyncratic toxicity in vivo.
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Introduction
Mefenamic acid (MFA), (2',3')-dimethyl-N-phenyl-anthranilic acid, is a carboxylic acidcontaining nonsterodial anti-inflammatory drug (NSAID) associated with a rare, but sometimes serious idiosyncratic nephrotoxicity (Robertson et al., 1980; Drury et al., 1981; Woods, 1981; Taha et al., 1985) and possibly hepatotoxicity (Somchit et al., 2004) . A proposed mechanism for the occurrence of these MFA induced toxicities suggests that MFA undergoes bioactivation into chemically-reactive acyl-linked metabolites that ultimately become covalently bound to tissue proteins resulting in adverse immunological responses ( Figure 1 ). MFA is metabolized to 3-hydroxy-MFA (Glazko, 1966 ) and 3-carboxy-MFA (Sato et al., 1993) via cytochrome P450 2C9.
MFA also undergoes glucuronidation via uridine 5'-diphospho-glucuronosyltransferase (UGT) into the unstable, reactive acyl glucuronide metabolite, MFA-1-O-acyl-glucuronide (MFA-1-O-G) (Somchit et al., 2004; McGurk et al, 1996) . Acyl glucuronides of acidic drugs are proposed to bind covalently to protein via a direct transacylation reaction in which protein nucleophiles react with the facile carbonyl-carbon of the acyl glucuronide, resulting in the liberation of the glucuronic acid, and via the formation of a drug-protein conjugate or a glycation mechanism involving prior acyl migration of the drug on the glucuronic acid moiety permitting ring opening of the sugar resulting in an exposed reactive aldehyde group that reversibly forms an imine (Schiff's base) with an amine group on proteins. Subsequent Amadori rearrangement results in a stable ketoamine derivative in which both the drug and the glucuronic acid moiety become covalently bound onto the protein (Benet et al., 1993) . MFA is also metabolized into the reactive MFA-acyl-adenylate (MFA-AMP) and MFA-S-acyl-CoA (MFA-CoA) via acyl-CoA synthetase (ACS), both of which have been demonstrated to form glutathione (GSH)-adducts and are proposed to play a role in MFA mediated idiosyncratic toxicity (Grillo et al., 2012; Horng and This article has not been copyedited and formatted. The final version may differ from this version. 6 Benet, 2013) . This pathway occurs when the adenosine monophosphate (AMP) moiety of ATP is covalently transferred to the carboxyl group of MFA to form MFA-AMP, followed by the displacement of the AMP with coenzyme A (CoA) to form MFA-CoA thioesters (Kelley and Vessey, 1994; Mano et al., 2001) . Upon their formation, the carbonyl carbon of both MFA-AMP and MFA-CoA increase in electrophilicity enabling them to transacylate the biological nucleophile GSH (Horng and Benet, 2013) . It is proposed that these drug-protein adducts could act as haptens and are recognized by the immune system as foreign, illiciting an autoimmune type response resulting in the associated idiosyncratic toxicity (Uetrecht, 2007) . Previous in vitro incubations with the model nucleophile glutathione (GSH) under physiological conditions showed MFA-AMP to be reactive towards GSH, but 11-fold less reactive than MFA-CoA, while MFA-1-O-G exhibited little GSH reactivity (Horng and Benet, 2013) . In vitro rat hepatocyte incubations have also resulted in the detection of MFA-AMP, MFA-CoA, MFA-1-O-G, and MFA-GSH (Horng and Benet, 2013) , all of which could be more reactive than MFA per se and potentially involved in the formation of drug-protein adducts. Additionally, studies involving the acyl-linked metabolites of the bile acid, cholic acid (CA), revealed that CA-AMP selectively reacts non-enzymatically with amino functional groups while CA-CoA preferentially reacts nonenzymatically with thiol functional groups (Mitamura et al., 2011) .
The following experiments were designed to characterize the non-enzymatic acylation of the nucleophilic biomolecules containing the amino functional groups of glycine (Gly) and taurine are all selective towards their acylation of nucleophilic functional groups on biological molecules, all of which can contribute to the formation of MFA adducts with amino acids, peptides, and proteins. We also hypothesize that MFA-GSH is reactive in its own right due to its structural similarity to MFA-CoA via the thioester bond. If this proposal is correct, the reactive acyl-linked metabolites of MFA would be anticipated to be selective in their formation of drugprotein adducts in vivo, which may potentially mediate the idiosyncratic toxicities associated with MFA and other carboxylic acid-containing drugs.
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Instrumentation and Analytical Methods
HPLC/UV analysis was performed on a Hewlett Packard 1100 series binary pump HPLC system (Santa Clara, CA) coupled to a Hewlett Packard 1100 UV-Vis detector, utilizing HP Chemstation software for the acquisition of all HPLC/UV data. LC-MS/MS analyses of synthetic standards and in vitro samples were performed on a Shimadzu LC-20AD (Kyoto, Japan) HPLC system coupled to an Applied Biosystem/MDS Sciex API (Framingham, MA) 4000 triple quadrupole mass spectrometer outfitted with a Turbo V ion source using positive ionization mode. All LC-MS/MS analyses were performed on a reverse phase column (XTerra This article has not been copyedited and formatted. The final version may differ from this version. The synthesis of MFA-AMP, MFA-Gly, MFA-NAC, and MFA-Tau was carried out with a solution consisting of 110 mg N,N'-dicyclohexylcarbodiimide in 0.4 ml pyridine (Ikegawa et al., 1999; Horng and Benet, 2013) . Briefly, an N,N'-dicyclohexylcarbodiimide solution was added to a solution containing MFA (0.49 mmol), and either AMP, Gly, Tau, or NAC (0.49 mmol) separately in 75% pyridine/25% water. The reaction mixture was stirred at 4 o C for 7 hr and then centrifuged at 3000 rpm for 5 min to remove any N-acylurea derivatives. The supernatant was transferred to another culture tube for precipitation by the addition of acetone (10 ml). The resulting precipitate was isolated by centrifugation at 3000 rpm for 5 min followed by further washes with acetone (10 x 10 ml) and acidified water (pH 4-5) (10 x 10 ml). HCl, the MFA-AMP was further washed with acetone (10 x 10 ml). The MFA-AMP precipitate was blown down to dryness using N 2 gas and weighed out for preparation of a 1 mM MFA-AMP solution in DMSO. For MFA-Gly, MFA-NAC, and MFA-Tau, the initial acetone derived precipitate was dissolved in DMSO and subjected to purification via HPLC/UV-mass spectrometry. The correct HPLC eluent fractions, as determined by UV-MS, of each acyl-linked metabolite were collected, blown down to dryness, weighed, and then prepared as 1 mM solutions in DMSO. MFA-AMP eluted at a retention time of 7.6 min and showed no impurities when analyzed by HPLC/UV (wavelengths: 220, 254, 262, and 280 nm) and LC-MS via reversephase gradient elution (as described above), and 1 H NMR (Horng and Benet, 2013) . Tandem and 4B).
Synthesis of MFA-CoA and MFA GSH Thioester Derivatives
The synthesis of MFA-CoA and MFA-GSH thioesters was accomplished by a method employing ECF (Stadtman, 1957; Grillo et al., 2002; Horng and Benet, 2013) as described previously.
Briefly, MFA (1.6 mmol) was dissolved in anhydrous THF (25 ml). While stirring at room temperature, TEA (1.6 mmol) was added to the solution followed by the addition of ECF (1.6 mmol). After 30 min, the resulting triethylamine hydrochloride was removed by passing the reaction mixture through a glass funnel fitted with a glass wool plug. The filtered solution was then added to a solution containing CoA (0.13 mmol, 100 mg) or GSH (1 g) and KHCO 3 (1.6 mmol) in nanopure water (10 ml) and THF (15 ml). The solution was stirred continuously at room temperature for 2 hr, after which the reaction was terminated by acidification (pH 4-5) through the addition of 1 M HCl. THF was then removed by evaporation under N 2 gas, followed by further solvent washes: acidified water (pH 5) (3 x 10 ml) and ethyl acetate (3 x 10 ml) for MFA-CoA or acetone (3 x 10 ml) for MFA-GSH. MFA-CoA and MFA-GSH precipitate was blown down to dryness using N 2 gas and then weighed out for preparation of a 1 mM MFA-CoA This article has not been copyedited and formatted. The final version may differ from this version. 
In Vitro Studies with Rat Hepatocytes
Freshly isolated rat (250-300 g, male Sprague-Dawley) hepatocytes were prepared according to the method of Moldeus et al. (1978) and greater than 85% viability was achieved routinely as with MFA, as previously described (Horng and Benet, 2013) . MFA-AMP, MFA-CoA, MFA-GSH, and MFA-1-O-G formed in rat hepatocyte extracts and authentic standards coeluted at retention times of 7.6, 7.3, 7.7, and 7.9 min, respectively, and the product ion spectrum of each conjugate was consistent with its chemical structure and identical to its corresponding authentic standard.
Identification of MFA-Tau
Analysis of rat hepatocyte extracts incubated with MFA by LC-MS/MS detection allowed for the identification of MFA-Tau formed in incubations with MFA. MFA-Tau formed in rat hepatocyte extracts and authentic standard coeluted at a retention time of 9.1 min ( Figure 3C) and the product ion spectrum of the conjugate was consistent with its chemical structure and identical to its corresponding authentic standard. MFA-Gly and MFA-NAC were not detected in MFA rat hepatocyte incubations.
Chemical Stability of MFA-CoA, MFA-AMP, MFA-GSH, MFA-NAC, MFA-Gly, and
MFA-Tau in Buffer
Discussion
Carboxylic acid-containing drugs are metabolized into reactive electrophilic acyl-linked metabolites that can form irreversible adducts with proteins, potentially causing an allergic reaction in hypersensitive individuals (Stogniew and Fenselau, 1982) . MFA is an NSAID prescribed for its analgesic and anti-inflammatory activity via inhibition of cyclooxygenasedependent prostanoid formation (Hawkey, 1999) . Commonly used to treat pain, MFA has been implicated in several cases of hepatic and renal disturbances and hypersensitivity reactions (Handisurya et al., 2011) . These toxicities are proposed to occur via bioactivation of MFA into reactive acyl-linked metabolites covalently binding onto macromolecules. MFA undergoes conjugation via the free carboxyl group into the 1-O-acyl glucuronide, MFA-1-O-G (Glazko, 1966; Sato et al., 1993) , which has been shown to irreversibly bind to albumin (McGurk et al., 1996) . MFA also undergoes further conjugation into MFA-AMP, MFA-CoA and MFA-GSH (Grillo et al., 2012; Horng and Benet, 2013) in rat hepatocytes, all of which possess an increased chemical electrophilicity and are reactive towards protein nucleophiles.
Electrophilicity assessment of metabolites in drug development involve screens utilizing nucleophilic trapping agents. Glutathione is a commonly used biomarker of reactivity for bioactivation studies. Presumably, the greater the in vitro nucleophilic adduct formation, the greater the probability it will covalently bind onto proteins and elicit a toxic reaction. However, not all protein covalent binding result in the onset of toxicity, and thus the challenge is to identify those protein targets that are critical for the onset of a drug induced toxicity. In addition to thioesters (Van Breemen and Fenselau, 1985) , acyl-linked metabolites have also been shown to (Wells and Janssen, 1987) and amide-linkage (van Breemen and Fenselau, 1986; Mitamura et al., 2011) . In the present study, we investigate the selective non-enzymatic acylation of amino and thiol functional groups of four biological nucleophiles:
Gly, Tau, GSH, and NAC.
In vitro GSH reactivity assessment of MFA-AMP, MFA-CoA, and MFA-1-O-G revealed MFACoA to be 11.5-fold more reactive than MFA-AMP toward the thiol functional group of GSH ( Figure 7A ), consistent with our previous studies (Horng and Benet, 2013) , while MFA-CoA was 19.5-fold more reactive toward the thiol groups of NAC than its corresponding MFA-AMP ( Figure 7B ). Alternatively, incubations with Gly and Tau revealed that MFA-AMP is more reactive towards N-acyl-amidation than its corresponding MFA-CoA, producing a significant amount of MFA-Gly while MFA-CoA did not react with Gly ( Figure 6A ). The amidation of Tau by MFA-AMP was also 17.5-fold greater than MFA-CoA ( Figure 6B ). MFA-1-O-G exhibited little to no reactivity towards all four bionucleophiles. Reactivity data were linear during the incubation and therefore the 60 min time point was used to calculate the slope of conjugate formation (Table 1) . Reactivity studies utilizing cholic acid have also demonstrated a greater reactivity of CA-AMP compared to CA-CoA towards the N-acyl-amidation of glycine and taurine, while CA-CoA exhibited a greater reactivity towards the acylation of the cysteinesulfhydryl group of GSH and NAC (Mitamura et al., 2011) . Studies in buffer also show that acyl-adenylates can spontaneously react with the amino groups of substance P ), lysozomes (Goto et al., 2005) , and histones (Mano et al., 2004) , further suggesting that acyl-adenylates have a high reactive affinity towards amino functional groups, and that acyl- Acyl-GSH conjugates share a common structural moiety, thioester, to that of the acyl-CoA.
Therefore, it is conceivable that MFA-GSH is just as, if not more reactive than its corresponding acyl-CoA derivative. NAC reactivity assessments show that MFA-GSH is indeed highly reactive, exhibiting a 5.5-fold and 108-fold greater reactivity towards NAC than MFA-CoA and MFA-AMP, respectively ( Figure 7B ). Grillo and Benet (2002) have demonstrated that the reactive potential of S-acyl-glutathione conjugates with NAC correlates to the degree of α -carbon substitution of the acyl-linkage, increasing α -carbon substitution results in decreasing reactivity, which is in agreement with the relative degradation rates associated with acyl glucuronides and assumed to be identical for that of their respective S-acyl-CoA thioesters.
Therefore, if MFA toxicity is the result of covalent binding by reactive intermediates, then it is conceivable that the unusually high formation of MFA-GSH in rat hepatocytes (Grillo et al., 2012; Horng and Benet, 2013 ), compared to diclofenac (Grillo et al., 2003) , zomepirac (Olsen et al., 2005) , (R)-ibuprofen (Grillo and Hua, 2008) , and (R)-flunoxaprofen (Grillo et al., 2010) , may be responsible for the tissue injury associated with MFA. This assumption is based on the high covalent binding values in animals dosed with drugs known to cause hepatotoxicity in humans, such as isoniazid (Nelson et al., 1978) and acetaminophen (Matthews, 1997) .
This article has not been copyedited and formatted. The final version may differ from this version. yield the associated acyl-CoA product and free AMP (Vlahcevic et al., 1999) . Acyl-CoA and acyl-AMP metabolites both spontaneously and enzymatically, via glutathione-S-transferase, form GSH-conjugates (Li et al.,2002; Grillo et al., 2012; Horng and Benet, 2013) . In addition to GSH, glycine (Keller and Keller, 1842) and taurine (James et al., 1971; Hutson and Casida, 1978) Tau, and ZP-Gly (Olsen et al., 2005) . The high concentration of ZP-1-O-G compared to ZP-Gly and ZP-Tau may be reflective of dose, a determinant of whether or not a drug undergoes glucuronidation or amino acid conjugation (Hutt and Caldwell, 1990) . At lower doses, carboxylic acids tend to undergo amino acid conjugation while at higher doses, glucuronidation dominates. Amino acid conjugation is a high-affinity, low capacity system while glucuronidation is a high-capacity pathway with a broader substrate selectivity. Dose also influences the type of amino acid conjugate formed (Hirom et al., 1977) , with dosage increases of phenylacetic acid resulting in decreases in glycine:taurine conjugate ratios. Rat liver experiments with tolmetin (Tol) also identified the acyl-CoA derived conjugates, Tol-Gly and
Tol-Tau conjugates in rat urine (Olsen et al., 2003) , whose concentrations were unaffected by clofibric acid, confirming a high-affinity/low-capacity metabolic pathway (Hutt and Caldwell, 1990) . Oral administration of RS-ibuprofen to humans also led to the detection of ibuprofen-Tau but not the glycine conjugate (Shirley et al., 1994) , signifying a minor biotransformation pathway. Gly and Tau conjugates are believed to be formed enzymatically (N-acyltransferases) via the acyl-CoA, however we have demonstrated that Gly and Tau conjugates also form spontaneously via acyl-AMP conjugates. MFA-NAC conjugates were not detected in rat hepatocyte incubations, due to the lack of detectable N-acylcysteinylglycine and glutamyl transpeptidase (γ-GT) activity in rat livers (Hinchman and Ballatori, 1990) . However, in humans, NAC formation would be expected to occur.
In conclusion, MFA-AMP selectively reacts nonenzymatically with the amino functional groups of glycine and lysine, while MFA-CoA selectively reacts nonenzymatically with the thiol functional groups of GSH and NAC. MFA-GSH is also reactive towards NAC, which may be of 
